Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID Multinational Cohort study
<p>At the beginning of the COVID-19 pandemic, the extent of the risks of a COVID infection during pregnancy were unknown. During the start of the pandemic, there were only a few studies published comparing outcomes between pregnant women with and without COVID-19 infections. The INTERGROWTH-21...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Lippincott, Williams and Wilkins
2022
|
| _version_ | 1817931375219572736 |
|---|---|
| author | Villar, J Ariff, S Gunier, RB Thiruvengadam, R Rauch, S Kholin, A Roggero, P Prefumo, F do Vale, MS Cardona-Perez, JA Maiz, N Cetin, I Savasi, V Deruelle, P Easter, SR Sichitiu, J Conti, CPS Ernawati, E Mhatre, M Teji, JS Liu, B Capelli, C Oberto, M Salazar, L Gravett, MG Cavoretto, PI Nachinab, VB Galadanci, H Oros, D Ayede, AI Sentilhes, L Bako, B Savorani, M Cena, H García-May, PK Etuk, S Casale, R Abd-Elsalam, S Ikenoue, S Aminu, MB Vecciarelli, C Duro, EA Usman, MA John-Akinola, Y Nieto, R Ferrazi, E Bhutta, ZA Langer, A Kennedy, SH Papageorghiou, AT |
| author_facet | Villar, J Ariff, S Gunier, RB Thiruvengadam, R Rauch, S Kholin, A Roggero, P Prefumo, F do Vale, MS Cardona-Perez, JA Maiz, N Cetin, I Savasi, V Deruelle, P Easter, SR Sichitiu, J Conti, CPS Ernawati, E Mhatre, M Teji, JS Liu, B Capelli, C Oberto, M Salazar, L Gravett, MG Cavoretto, PI Nachinab, VB Galadanci, H Oros, D Ayede, AI Sentilhes, L Bako, B Savorani, M Cena, H García-May, PK Etuk, S Casale, R Abd-Elsalam, S Ikenoue, S Aminu, MB Vecciarelli, C Duro, EA Usman, MA John-Akinola, Y Nieto, R Ferrazi, E Bhutta, ZA Langer, A Kennedy, SH Papageorghiou, AT |
| author_sort | Villar, J |
| collection | OXFORD |
| description | <p>At the beginning of the COVID-19 pandemic, the extent of the risks of a COVID infection during pregnancy were unknown. During the start of the pandemic, there were only a few studies published comparing outcomes between pregnant women with and without COVID-19 infections. The INTERGROWTH-21st Consortium conducted a prospective, longitudinal, observational study (INTERCOVID), which assessed the association between COVID-19 and maternal/neonatal outcomes in pregnant women with a COVID-19 diagnosis compared with enrolled pregnant women without a COVID-19 diagnosis.</p>
<p>This study enrolled patients from 43 hospitals in 18 different countries between March 2020 and October 2020. As a comparison group, the researchers enrolled 2 unmatched, consecutive, uninfected women immediately after each infected woman was identified, at any stage of pregnancy or delivery, and at the same level of care. Both women and neonates were followed until hospital discharge. COVID-19 was diagnosed by laboratory confirmation and/or radiological pulmonary findings or 2 or more predefined COVID-19 symptoms. The primary outcomes of the study were indices of maternal and severe neonatal/perinatal morbidity and mortality.</p>
<p>In all, 706 pregnant women with a COVID-19 diagnosis and 1424 pregnant women without a COVID-19 diagnosis were enrolled. The women had broadly similar demographic characteristics (mean [SD] age, 30.2 [6.1] years). Three hundred twenty-three women were overweight early in pregnancy (48.6%) with COVID-19 diagnosis and 554 women (40.2%) without. Women with COVID-19 diagnosis were more likely to have preeclampsia/eclampsia (relative risk [RR], 1.76; 95% CI, 1.27–2.43), severe infections (RR, 3.38; 95% CI, 1.63–7.01), intensive care unit admission (RR, 5.04; 95% CI, 3.13–8.10), maternal mortality (RR, 22.3; 95% CI, 2.88–172), preterm birth (RR, 1.59; 95% CI, 1.30–1.94), medically indicated preterm birth (RR, 1.97; 95% CI, 1.56–2.51), severe neonatal morbidity index (RR, 2.66; 95% CI, 1.69–4.18), and severe perinatal morbidity and mortality index (RR, 2.14; 95% CI, 1.66–2.75). Women with a fever and shortness of breath were more likely to have severe maternal complications (RR, 2.56; 95% CI, 1.92–3.40) and neonatal complications (RR, 4.97; 95% CI, 2.11–11.69). Women who were asymptomatic with a COVID-19 diagnosis remained at higher risk only for maternal morbidity (RR, 1.24; 95% CI, 1.00–1.54) and preeclampsia (RR, 1.63; 95% CI, 1.01–2.63). Among women who tested positive for COVID-19 (98.1% by real-time polymerase chain reaction), 54 (13%) of their neonates tested positive. Cesarean delivery (RR, 2.15; 95% CI, 1.18–3.91) but not breastfeeding (RR, 1.10; 95% CI, 0.66–1.85) was associated with increased risk for neonatal COVID-19 test positivity.</p>
<p>In this study, COVID-19 in pregnancy was associated with consistent and substantial increases in severe maternal morbidity and mortality and neonatal complications compared with pregnant women without a COVID-19 diagnosis. These findings highlight the importance of following the recommended COVID-19 preventative measures.</p> |
| first_indexed | 2024-12-09T03:21:01Z |
| format | Journal article |
| id | oxford-uuid:02e15e43-8559-425d-aace-2401f0c1d487 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-12-09T03:21:01Z |
| publishDate | 2022 |
| publisher | Lippincott, Williams and Wilkins |
| record_format | dspace |
| spelling | oxford-uuid:02e15e43-8559-425d-aace-2401f0c1d4872024-11-12T13:44:49ZMaternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID Multinational Cohort studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:02e15e43-8559-425d-aace-2401f0c1d487EnglishSymplectic ElementsLippincott, Williams and Wilkins2022Villar, JAriff, SGunier, RBThiruvengadam, RRauch, SKholin, ARoggero, PPrefumo, Fdo Vale, MSCardona-Perez, JAMaiz, NCetin, ISavasi, VDeruelle, PEaster, SRSichitiu, JConti, CPSErnawati, EMhatre, MTeji, JSLiu, BCapelli, COberto, MSalazar, LGravett, MGCavoretto, PINachinab, VBGaladanci, HOros, DAyede, AISentilhes, LBako, BSavorani, MCena, HGarcía-May, PKEtuk, SCasale, RAbd-Elsalam, SIkenoue, SAminu, MBVecciarelli, CDuro, EAUsman, MAJohn-Akinola, YNieto, RFerrazi, EBhutta, ZALanger, AKennedy, SHPapageorghiou, AT<p>At the beginning of the COVID-19 pandemic, the extent of the risks of a COVID infection during pregnancy were unknown. During the start of the pandemic, there were only a few studies published comparing outcomes between pregnant women with and without COVID-19 infections. The INTERGROWTH-21st Consortium conducted a prospective, longitudinal, observational study (INTERCOVID), which assessed the association between COVID-19 and maternal/neonatal outcomes in pregnant women with a COVID-19 diagnosis compared with enrolled pregnant women without a COVID-19 diagnosis.</p> <p>This study enrolled patients from 43 hospitals in 18 different countries between March 2020 and October 2020. As a comparison group, the researchers enrolled 2 unmatched, consecutive, uninfected women immediately after each infected woman was identified, at any stage of pregnancy or delivery, and at the same level of care. Both women and neonates were followed until hospital discharge. COVID-19 was diagnosed by laboratory confirmation and/or radiological pulmonary findings or 2 or more predefined COVID-19 symptoms. The primary outcomes of the study were indices of maternal and severe neonatal/perinatal morbidity and mortality.</p> <p>In all, 706 pregnant women with a COVID-19 diagnosis and 1424 pregnant women without a COVID-19 diagnosis were enrolled. The women had broadly similar demographic characteristics (mean [SD] age, 30.2 [6.1] years). Three hundred twenty-three women were overweight early in pregnancy (48.6%) with COVID-19 diagnosis and 554 women (40.2%) without. Women with COVID-19 diagnosis were more likely to have preeclampsia/eclampsia (relative risk [RR], 1.76; 95% CI, 1.27–2.43), severe infections (RR, 3.38; 95% CI, 1.63–7.01), intensive care unit admission (RR, 5.04; 95% CI, 3.13–8.10), maternal mortality (RR, 22.3; 95% CI, 2.88–172), preterm birth (RR, 1.59; 95% CI, 1.30–1.94), medically indicated preterm birth (RR, 1.97; 95% CI, 1.56–2.51), severe neonatal morbidity index (RR, 2.66; 95% CI, 1.69–4.18), and severe perinatal morbidity and mortality index (RR, 2.14; 95% CI, 1.66–2.75). Women with a fever and shortness of breath were more likely to have severe maternal complications (RR, 2.56; 95% CI, 1.92–3.40) and neonatal complications (RR, 4.97; 95% CI, 2.11–11.69). Women who were asymptomatic with a COVID-19 diagnosis remained at higher risk only for maternal morbidity (RR, 1.24; 95% CI, 1.00–1.54) and preeclampsia (RR, 1.63; 95% CI, 1.01–2.63). Among women who tested positive for COVID-19 (98.1% by real-time polymerase chain reaction), 54 (13%) of their neonates tested positive. Cesarean delivery (RR, 2.15; 95% CI, 1.18–3.91) but not breastfeeding (RR, 1.10; 95% CI, 0.66–1.85) was associated with increased risk for neonatal COVID-19 test positivity.</p> <p>In this study, COVID-19 in pregnancy was associated with consistent and substantial increases in severe maternal morbidity and mortality and neonatal complications compared with pregnant women without a COVID-19 diagnosis. These findings highlight the importance of following the recommended COVID-19 preventative measures.</p> |
| spellingShingle | Villar, J Ariff, S Gunier, RB Thiruvengadam, R Rauch, S Kholin, A Roggero, P Prefumo, F do Vale, MS Cardona-Perez, JA Maiz, N Cetin, I Savasi, V Deruelle, P Easter, SR Sichitiu, J Conti, CPS Ernawati, E Mhatre, M Teji, JS Liu, B Capelli, C Oberto, M Salazar, L Gravett, MG Cavoretto, PI Nachinab, VB Galadanci, H Oros, D Ayede, AI Sentilhes, L Bako, B Savorani, M Cena, H García-May, PK Etuk, S Casale, R Abd-Elsalam, S Ikenoue, S Aminu, MB Vecciarelli, C Duro, EA Usman, MA John-Akinola, Y Nieto, R Ferrazi, E Bhutta, ZA Langer, A Kennedy, SH Papageorghiou, AT Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID Multinational Cohort study |
| title | Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID Multinational Cohort study |
| title_full | Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID Multinational Cohort study |
| title_fullStr | Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID Multinational Cohort study |
| title_full_unstemmed | Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID Multinational Cohort study |
| title_short | Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID Multinational Cohort study |
| title_sort | maternal and neonatal morbidity and mortality among pregnant women with and without covid 19 infection the intercovid multinational cohort study |
| work_keys_str_mv | AT villarj maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT ariffs maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT gunierrb maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT thiruvengadamr maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT rauchs maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT kholina maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT roggerop maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT prefumof maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT dovalems maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT cardonaperezja maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT maizn maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT cetini maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT savasiv maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT deruellep maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT eastersr maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT sichitiuj maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT conticps maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT ernawatie maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT mhatrem maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT tejijs maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT liub maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT capellic maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT obertom maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT salazarl maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT gravettmg maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT cavorettopi maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT nachinabvb maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT galadancih maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT orosd maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT ayedeai maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT sentilhesl maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT bakob maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT savoranim maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT cenah maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT garciamaypk maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT etuks maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT casaler maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT abdelsalams maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT ikenoues maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT aminumb maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT vecciarellic maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT duroea maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT usmanma maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT johnakinolay maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT nietor maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT ferrazie maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT bhuttaza maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT langera maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT kennedysh maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy AT papageorghiouat maternalandneonatalmorbidityandmortalityamongpregnantwomenwithandwithoutcovid19infectiontheintercovidmultinationalcohortstudy |